The HKAPI is pleased to announce that the 57th Annual General Meeting (AGM) was held successfully on 26 March 2025, with over 50 General Managers and Senior Management in attendance.
We are excited to share that approximately 120 members joined the recent seminar on Value-Based Medicine, hosted by HKAPI's catalyst member, Vista Health. The seminar focused on "Best Practices in Real-World Data: Perspectives from Outside of Hong Kong," providing valuable insights into the application of real-world evidence (RWE) in healthcare decision-making.
On February 25, the HKAPI Chronic Disease Co-Care Scheme (CDCC) & Community Drug Formulary (CDF) Project Team hosted an online sharing session with over 100 members participating.
"Developing Hong Kong as a Medical Innovation Hub," was held in collaboration with OASES. This event gathered prominent experts from Hong Kong's dynamic life and health technology sectors to showcase the city’s potential as a leading center for medical innovation.
We are delighted to announce our collaboration with the HKU LKS Faculty of Medicine's Department of Pharmacology and Pharmacy, the Jockey Club PHARM+ Community Medication Service Network, the Sha Tin District Health Centre Express, and our Associate Member, Chinachem Group, to organize a health day event for the elderly residents of Golden Lion Garden.
We are delighted to welcome Edelman as the first Catalyst Member of the Hong Kong Association of the Pharmaceutical Industry (HKAPI) since the recent membership restructure.
HKAPI celebrated its 56th anniversary with an annual dinner held on June 20th, 2024 at the JW Marriott Hong Kong. The event brought together over 300 guests, including government officials, patient groups, academia, healthcare partners, NGOs, and industry members.